•
Long-term survival after SBRT may be achieved in
patients with favorable prognostic factors:
–
Colorectal and prostate primaries
–
Good performance status
–
Small size of the metastases
–
Low number of metastases
•
Few patients with grade > 3 morbidities
•
Candidates for SBRT should enter phase III trials
Conclusions – SBRT of abdomino-pelvic
oligometastases
Conclusions – SBRT in palliation
Experience based on selected patients